Clinical TrialsSearch results
Number of results: 819
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Excessive supragastric belching and rumination syndrome in phychosomatic disorders.
- psychosomatic disorders ,supragastric belching, rumination syndrome
- Masui Daisuke
- 2021-09-28
Completed
- Clinical study of patient-proposed healthcare services with dabrafenib and trametinib for BRAF V600 mutant pediatric glioma
- BRAF V600 mutant progressive glioma
- Koga Yuhki
- 2021-09-16
Other
- CHAMPION-AF Clinical Trial
- Non-valvular atrial fibrillation
- Kawahara Kazuo
- 2021-09-14
Completed
- A Phase 1 Mass Balance Study of Oral [14C] TAS-115 in Healthy Adult Male Subjects
- Chronic fibrosing interstitial lung diseases with a progressive phenotype
- Huang Jinhong
- 2021-09-07
Other
- SPIRAL-ANA study
- non-small cell lung cancer
- Uchino Junji
- 2021-08-24
Other
- A Phase II study of Durvalumab (MEDI4736) plus carboplatin and etoposide in elderly patients with extensive-stage small-cell lung cancer
- extensive-stage small cell lung cancer
- Koichi Azuma
- 2021-08-05
Completed
- A study in healthy Japanese men to test how well different doses
of BI 1569912 are tolerated
- Major Dipressive Disorder
- Furuichi Takumi
- 2021-06-23
Other
- LOGIK2001(SPEED)
- extensive disease small Cell Lung Cancer(ED-SCLC)
- Okamoto Isamu
- 2021-06-21
Recruiting
- Induction of remission and consolidation therapy using ATRA and ATO for acute promyelocytic leukemia - JSCT APL2021 -
- Acute promyelocytic leukemia
- Takase Ken
- 2021-06-18
Recruiting
- The ALIGN Study is a phase 3, double-blind, placebo-controlled study to compare the efficacy and safety of atrasentan to placebo in patients with IgA nephropathy (IgAN) at risk of progressive loss of renal function
- IgA Nephropathy at Risk of Progressive Loss of Renal Function
- Fukui Tomoaki
- 2021-05-25